Antibody Response of Heterologous vs Homologous Messenger RNA Vaccine Boosters Against the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant: Interim Results from the PRIBIVAC Study, a Randomized Clinical Trial.
Saved in:
| Title: | Antibody Response of Heterologous vs Homologous Messenger RNA Vaccine Boosters Against the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant: Interim Results from the PRIBIVAC Study, a Randomized Clinical Trial. |
|---|---|
| Authors: | Poh XY; National Centre for Infectious Diseases, Singapore, Singapore., Tan CW; Emerging Infectious Diseases Programme, Duke-National University of Singapore Medical School, Singapore, Singapore., Lee IR; National Centre for Infectious Diseases, Singapore, Singapore., Chavatte JM; National Centre for Infectious Diseases, Singapore, Singapore.; National Public Health Laboratory, Singapore, Singapore., Fong SW; A*STAR Infectious Diseases Lab, Agency for Science Technology and Research, Singapore, Singapore., Prince T; Department of Infection Biology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom., Hartley C; Department of Infection Biology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom., Yeoh AYY; Emerging Infectious Diseases Programme, Duke-National University of Singapore Medical School, Singapore, Singapore., Rao S; National Centre for Infectious Diseases, Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore., Chia PY; National Centre for Infectious Diseases, Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore., Ong SWX; National Centre for Infectious Diseases, Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore., Lee TH; National Centre for Infectious Diseases, Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore., Sadarangani SP; National Centre for Infectious Diseases, Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore., Lin RJH; National Centre for Infectious Diseases, Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore., Lim C; National Centre for Infectious Diseases, Singapore, Singapore., Teo J; National Centre for Infectious Diseases, Singapore, Singapore., Lim DRX; National Centre for Infectious Diseases, Singapore, Singapore.; National Public Health Laboratory, Singapore, Singapore., Chia W; Emerging Infectious Diseases Programme, Duke-National University of Singapore Medical School, Singapore, Singapore., Hiscox JA; A*STAR Infectious Diseases Lab, Agency for Science Technology and Research, Singapore, Singapore.; Department of Infection Biology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom., Ng LFP; A*STAR Infectious Diseases Lab, Agency for Science Technology and Research, Singapore, Singapore.; Department of Infection Biology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Ren EC; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Singapore Immunology Network, Agency for Science Technology and Research, Singapore, Singapore., Lin RTP; National Centre for Infectious Diseases, Singapore, Singapore.; National Public Health Laboratory, Singapore, Singapore., Renia L; A*STAR Infectious Diseases Lab, Agency for Science Technology and Research, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.; School of Biological Sciences, Nanyang Technological University, Singapore, Singapore., Lye DC; National Centre for Infectious Diseases, Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Wang LF; Emerging Infectious Diseases Programme, Duke-National University of Singapore Medical School, Singapore, Singapore., Young BE; National Centre for Infectious Diseases, Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2022 Dec 19; Vol. 75 (12), pp. 2088-2096. |
| Publication Type: | Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1537-6591 |
|---|---|
| DOI: | 10.1093/cid/ciac345 |
